Prostate Cancer: Interprofessional Collaboration and Pharmacologic Care

Course overview

Prostate cancer is the most frequently diagnosed cancer among men and a leading cause of cancer-related mortality. Approximately one in eight men will be diagnosed with prostate cancer during their lifetime. Despite advancements in screening and treatment, this condition remains a public health challenge due to its heterogeneity, variable progression, and disparities in outcomes across racial and socioeconomic populations. Within this continuing education activity, participants will review the etiology, risk factors, staging, and diagnosis of prostate cancer. This activity will also review available treatment options, including chemotherapy, hormone therapy, immunotherapy, and emerging agents. Throughout the activity, an emphasis will be placed on interprofessional communication and shared decision-making.